Advanced Search

Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2003 September;45(3) > Panminerva Medica 2003 September;45(3):183-8

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEPANMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Frequency: Quarterly

ISSN 0031-0808

Online ISSN 1827-1898

 

Panminerva Medica 2003 September;45(3):183-8

    REVIEWS

Infectious agents and gastric tumours. An increasing role for Epstein-Barr virus

Mladenova I. 1, Pellicano R. 2

1 Department of Epidemiology, Medical Faculty, Stara Zagora, Bulgaria
2 Department of Gastro-Hepatology, Molinette Hospital, Turin, Italy

Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) are 2 common and widely disseminated agents throughout the world. H. pylori has been classified, by the International Agency for Research on Cancer conference, as a class I carcinogen, i.e. undoubted cause of gastric cancer. However, this infection does not explain all the epidemiological and histological variations of the malignancies affecting the stomach. EBV has been identified, in the last decade, in the tumour cells of patients with gastric carcinoma and recent findings suggest the possibility of distinct mechanisms in its pathogenesis. A prevalent role of the virus has been described in a subset of stomach cancers, namely lymphoepithelioma-like carcinomas. The present update attempts to focus on the epidemiological evidence and the biological plausibility for a causal role of H.pylori and EBV infection in the pathogenesis of gastric cancer.

language: English


FULL TEXT  REPRINTS

top of page